BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 24, 2020
View Archived Issues
Phase IIb study of Rivelin-CLO achieves primary endpoint
Read More
Favorable safety seen with MERS-CoV vaccine MVA-MERS-S in phase I study
Read More
Cyp2c44 protects against breast tumor growth and metastasis by preventing PGE2 synthesis in mice
Read More
ARRB1 shows a tumor-suppressive function in T-ALL by promoting NOTCH1 degradation
Read More
AstraZeneca announces initiation of phase III DARE-19 study of Farxiga in COVID-19
Read More
First subject dosed in phase I study of TD-0903
Read More
RECCE-327 shows significant antibacterial activity against MRSA superbug in vivo
Read More
FDA recommends phase III confirmatory study of bucillamine in patients with COVID-19
Read More
Algernon receives approval for phase II COVID-19 study of ifenprodil in South Korea
Read More
First patient dosed in phase I study of SRF-388
Read More
MicroRNA biomarkers in malignant progression of gliomas
Read More
Angiotensin-(1-12) as novel biomarker of hypertension and cardiac disease
Read More
Annapurna Bio patents apelin receptor agonists
Read More
Pfizer discloses new PDE4B inhibitors
Read More
FORMA Therapeutics identifies USP30 inhibitors
Read More
Nippon Chemical Industrial describes new gold complexes for cancer
Read More
PTPN11 inhibitors presented by Gilead Sciences
Read More
New approach generates biohybrid microswimmers with nanoerythrosome carriers
Read More
Valneva and Dynavax collaborate on vaccine program for COVID-19
Read More
NCS1 is a potential therapeutic target for Wolfram syndrome
Read More
In antibody ensemble, second fiddles help the neutralizing stars
Read More
Phase IIa study of BIO-11006 shows reduced all-cause mortality from ARDS
Read More
Phase IIb study of RV-001 in prostate cancer treats first patient in Germany
Read More
Summary trial results for CL-2020 in acute myocardial infarction and ischemic stroke
Read More
Phase III PROfound trial of Lynparza in CRPC shows statistically significant improvement in OS
Read More
Phase I/II study of NOX-A12 in brain cancer cleared to begin second cohort
Read More
GARNET data show potential of dostarlimab in recurrent or advanced dMMR endometrial cancer
Read More